Last updated: 2026-09-16 09:05:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Avidity Biosciences, Inc. (RNAM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Avidity Biosciences, Inc. (RNAM) is trading at $-- in pre-market trading as of --, -- from the previous close of $--
Pre-market trading shows how investors are pricing RNAM before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, Avidity Biosciences, Inc. (RNAM) moved from $72.75 to $72.82, representing a gain of 0.10% ($0.07).
The stock traded between $72.75 and $73.04 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 16.84 million shares, -- versus the previous seven-day period, indicating -- trading activity.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. The company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 391 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Avidity Biosciences, Inc. (RNAM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.